NCT03430206View on ClinicalTrials.gov

Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) Use in Pediatric Procedures

NACompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

February 21, 2018

Primary Completion Date

October 2, 2018

Study Completion Date

October 2, 2018

Conditions
Oxygen DeficiencyDesaturation of BloodHypoventilationAnesthesia; Adverse Effect
Interventions
DEVICE

High-flow nasal cannula

While applied, the cannula will deliver high-flow rate oxygen, air, or a mixture of variable oxygen concentration (21-100%) depending on the surgical conditions and requirements. The rate will be set at 2L/kg/min with a maximum of 70L/min. This will be only for the duration of the surgery or procedure.

Trial Locations (1)

94305

Stanford University, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT03430206 - Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) Use in Pediatric Procedures | Biotech Hunter | Biotech Hunter